3Bibby K, Davis J, Jones C. Biopharmaceuticals - Moving to Centre Stage.2003 BioPeople North American Biotechnology Industry and Suppliers' Guide. 3～11,2003. IMS marketing research report.(http:∥www. imshealth. com/vgn/images/portal/cit_40000873/43028586
4Walsh G. Biopharmaceutic benchmarks-2003. Nature Biotechnnlogy. 2003,21: 870-878
5NEWS IN BRIEF. Gene therapy trial resumes. Nature Reviews Drug Discovery. 2004,3: 543
7Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998,282:1145-1147
8Shamblott MJ, Axelman J, Gearhart JD, et al. Derivation of pluripotent stem cells from cultured human primordial germ cells.Proc Natl Acad Sci USA. 1998,95:13726-13731
9Pavlou A, Reichert J. Monoclonal antibodies market. Nature Reviews Drug Discovery.2004. 3:383-384
10Riku Lahteenmaki, Laura DeFrancesco. Public biotechnology 2002-the numbers. Nature Biotech. 2003,21: 607-612
